Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
about
Surgical management of localised prostate cancerSurgical management of localised prostate cancerMotexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigenVascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insightMassive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapyHigh-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal modelCholine PET for monitoring early tumor response to photodynamic therapyFocal therapy for prostate cancer: rationale and treatment opportunities.Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.The role of focal therapy in the management of localised prostate cancer: a systematic review.New Monte Carlo model of cylindrical diffusing fibers illustrates axially heterogeneous fluorescence detection: simulation and experimental validation.Photodynamic therapy of cancer: an updateSynthesis, spectroscopic, and cellular properties of α-pegylated cis-A2B2- and A3B-types ZnPcsAccelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imagingVascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.Imaging techniques for prostate cancer: implications for focal therapySonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer.Recovery of optical properties using interstitial cylindrical diffusers as source and detector fibers.The role of photodynamic therapy (PDT) physics.Interstitial Photodynamic Therapy-A Focused ReviewOncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Photodynamic therapy: oncologic horizons.Health technology assessment in evolution - focal therapy in localised prostate cancer.The challenging landscape of medical device approval in localized prostate cancer.Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.Photosensitizers in prostate cancer therapy.Cobalt bis(dicarbollide) versus closo-dodecaborate in boronated chlorin e(6) conjugates: implications for photodynamic and boron-neutron capture therapy.Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity.Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradationThe effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model.Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.A Surgical View of Photodynamic Therapy in Oncology: A Review.Clinical development of photodynamic agents and therapeutic applications
P2860
Q24236194-012FFE2A-8E78-4CA6-9395-740F45A05FF8Q24240595-68035809-4DBF-437B-B2B8-63A354DAE3FEQ24647328-613C36F8-1683-4815-81EC-99A80B395058Q26750559-F0A59405-3A5C-446B-A099-548BABFEC0B2Q30823413-EF30853A-B083-4FBF-9337-2B66ECD8C52BQ33303889-1282D591-8945-4170-BCAE-035A5E1975D1Q33518345-9E02EFA6-3B85-4833-9396-611BDDE11BEAQ33702259-E541A4A3-5D8D-426D-A753-1967DBF0F756Q34068220-10216914-F592-4846-9870-4D800F25ACE6Q34266167-2D04BDEE-F0DD-4983-B3AA-C39C0B4E4161Q35194376-24ADF1A5-0C4F-49CD-BD2A-A5F2EEFD03FDQ35532394-F3C82D48-A767-4907-AB2A-08C90625AABEQ35694521-0FAD30F7-9A38-4BFF-9105-AA1F1E2EE832Q35984270-61B9087E-A33D-405D-A811-24A905346E82Q36107860-98413674-D989-4DB6-A70C-0C0DB73B27F4Q36388895-230C4B3F-2C67-4624-B8B4-9CB1B809C8DCQ36460818-CF71111F-A826-4707-90A8-4A0A8B77F92FQ36728850-D29F3493-BEA6-4FC5-8DD3-1EB04F2FADFFQ37116715-9D798201-A549-498D-9D83-814B3CB0CD71Q37170164-EE578376-1D5D-47DA-8D73-D650FD692E01Q37676062-A53A25AF-5279-411A-BF03-580ADBC7FFFEQ37676077-F0A017DB-FD68-49AA-A32C-D13EE47C3D26Q37919156-0B9BA194-612B-4F17-AA68-A3B4EAD58CD5Q38170385-C25B73DE-8767-4A3C-A2C1-9E8C1414DB41Q38223247-BCD6F29B-ACA7-4BE5-80AB-58384551FB37Q38668993-5E9CFC47-FED5-4E16-B85A-8ECB4040A2FCQ38739753-5CAABA19-311A-498C-8A8D-70B91CC2B396Q39254736-494F3BCD-EC6C-4B4D-9126-F5C552673337Q39409449-1059AB87-AB1A-4CBB-AB10-37A79B69D82FQ39483007-F47A4238-330C-4C0A-998C-0AD7EDCAEF41Q39965904-8AC54F33-3701-46A7-ABBD-4A56CF62DA1AQ41963527-83219ADA-0D5A-46A3-91C8-A14916BDD3CAQ43170864-5DA13E2E-A2F6-4224-9F16-B105294B255FQ45807605-E66F72D8-E2C6-47A8-9E84-FD7B165A38F7Q51898660-CB5BE334-E468-4DAA-B41C-029EC06CC355Q55018593-904CFFBC-0497-4151-B63D-194D53B816AFQ57069047-55190518-C479-4137-A3E8-FF6D33A84961
P2860
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@ast
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@en
type
label
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@ast
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@en
prefLabel
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@ast
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@en
P2093
P356
P1476
Photodynamic therapy using mes ...... HPC) in early prostate cancer.
@en
P2093
Emberton M
P2860
P304
P356
10.1002/LSM.20275
P577
2006-06-01T00:00:00Z